Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 30, 2007

PPD Plans Further Facility Construction in Scotland

  • PPD plans to expand its operations in Bellshill, Lanarkshire, and create approximately 390 additional jobs to meet the increasing demand for its drug development services.

    Located in Strathclyde Business Park, PPD currently employs more than 350 professionals in Scotland. The company expects to invest up to a total of £15 million to further expand its offices in this location over the next three years, creating new jobs in biostatistics, data management, pharmacovigilance, product development, and clinical trial management and monitoring.

    This investment will include the construction of a new 34,000-sq-ft facility to be built adjacent to the company's existing Fleming House offices, which were opened earlier this year and also comprise 34,000 square feet. PPD will continue to retain space at Avondale House in Strathclyde Business Park until the new facility is completed.

    PPD's expansion is being supported with a Regional Selective Assistance grant of £4.5 million.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »